Hidekazu Niwa
Overview
Explore the profile of Hidekazu Niwa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa Y, Iinuma Y, Okagawa T, Shimbo R, Enkhtuul B, Khurtsbaatar O, et al.
J Vet Med Sci
. 2025 Mar;
PMID: 40044168
Glanders is a World Organization for Animal Health (WOAH)-notifiable equine disease caused by the infection of Burkholderia mallei, and is endemic in Mongolia, South Asia, Africa, and South America. While...
2.
Hayashi M, Yonetamari J, Muto Y, Niwa H, Tanaka K
Microbiol Resour Announc
. 2025 Jan;
14(2):e0085424.
PMID: 39745437
is one of the major clinical anaerobic bacteria belonging to the family . Herein, we report the complete genome sequence of a clinical isolate of new species obtained from equine...
3.
Takahashi Y, Niwa H, Ebisuda Y, Mukai K, Yoshida T, Raidal S, et al.
Front Vet Sci
. 2024 Oct;
11:1477653.
PMID: 39430384
Introduction: Protection of horse welfare during transport is crucial. The aim of this study was to determine the effect of head and neck restraint on behavior and airway bacteria. Methods:...
4.
Nakajima K, Kasuya K, Senba H, Tagami K, Kinoshita Y, Niwa H
J Vet Med Sci
. 2024 Jun;
86(8):828-832.
PMID: 38897953
Strangles is a globally widespread, commonly diagnosed and important infectious disease of equids caused by Streptococcus equi subsp. equi. We performed whole genome sequencing of 19 S. equi isolates collected...
5.
Kuroda T, Minamijima Y, Niwa H, Mita H, Tamura N, Fukuda K, et al.
J Vet Med Sci
. 2024 Feb;
86(4):413-420.
PMID: 38346727
Fosfomycin (FOM) is an approved veterinary medicinal product for large animals in Japan, but Clinical breakpoint (CBP) for antimicrobial susceptibility test (AST) is not defined for animals. This study aimed...
6.
Kuroda T, Minamijima Y, Niwa H, Mita H, Tamura N, Fukuda K, et al.
J Equine Sci
. 2024 Jan;
34(4):111-114.
PMID: 38274556
A pharmacokinetic/pharmacodynamic (PK/PD) approach was used to determine a dosage regimen of cephalothin (CET) after intramuscular (IM) administration in horses. CET plasma concentrations were measured in eight horses after a...
7.
Uchida-Fujii E, Kuroda T, Niwa H, Kinoshita Y, Kano R, Tamura T, et al.
J Equine Vet Sci
. 2023 Dec;
133:104990.
PMID: 38159581
Infectious ulcerative keratitis is a common disease in racehorses. To improve treatment outcomes, this study aimed to assess the antimicrobial susceptibilities of bacterial and fungal isolates obtained from the cornea...
8.
Kinoshita Y, Niwa H, Uchida-Fujii E, Ueno T
J Vet Diagn Invest
. 2023 Nov;
36(1):108-111.
PMID: 37919953
is the predominant equine sp. isolated from clinically normal horses and is suspected to be associated with inflammatory airway disease in which cough is the primary sign. Quantitative evaluation of...
9.
Mita H, Kuroda T, Niwa H, Tamura N, Fukuda K, Ohta M
J Equine Sci
. 2023 Oct;
34(3):61-66.
PMID: 37781565
Surgical site infection (SSI) is one of the major complications of equine fracture surgery. The purpose of this study was to investigate the incidence of and risk factors for SSI...
10.
Uchida-Fujii E, Niwa H, Senoh M, Kato H, Kinoshita Y, Mita H, et al.
Sci Rep
. 2023 Aug;
13(1):13099.
PMID: 37567893
We encountered 34 Clostridioides difficile (C. difficile) infection (CDI) cases among Thoroughbred horses in Japan from 2010 to 2021. Among them, 79.4% (27/34) either died or were euthanised. The risk...